0001490109-12-000001.txt : 20120717 0001490109-12-000001.hdr.sgml : 20120717 20120717141341 ACCESSION NUMBER: 0001490109-12-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20120717 DATE AS OF CHANGE: 20120717 EFFECTIVENESS DATE: 20120717 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Carmot Therapeutics Inc. CENTRAL INDEX KEY: 0001490109 IRS NUMBER: 261872684 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-181381 FILM NUMBER: 12965484 BUSINESS ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 510-828-0102 MAIL ADDRESS: STREET 1: 409 ILLINOIS STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94158 D 1 primary_doc.xml X0706 D LIVE 0001490109 Carmot Therapeutics Inc. 409 ILLINOIS STREET SAN FRANCISCO CA CALIFORNIA 94158 510-828-0102 DELAWARE None None Corporation true 2008 Daniel A. Erlanson 409 Illinois Street San Francisco CA CALIFORNIA 94158 Executive Officer Director Stig K. Hansen 409 Illinois Street San Francisco CA CALIFORNIA 94158 Executive Officer Director Tim Kutzkey 1700 Owens Street Suite 595 San Francisco CA CALIFORNIA 94158 Director Dave Goeddel 1700 Owens Street Suite 595 San Francisco CA CALIFORNIA 94158 Director Biotechnology Decline to Disclose 06 false 2012-06-28 false true false 0 1200317 500159 700158 false 2 0 0 0 false Carmot Therapeutics Inc. /s/ Stig K. Hansen Stig K. Hansen Chief Executive Officer 2012-07-17